GlycoMimetics Ownership | Who Owns GlycoMimetics?

GlycoMimetics Ownership Summary

GlycoMimetics is owned by 19.48% institutional investors, 2.66% insiders, and 77.86% retail investors. Bvf inc/il is the largest institutional shareholder, holding 14.80% of GLYC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.98% of its assets in GlycoMimetics shares.

GLYC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	GlycoMimetics	19.48%	2.66%	77.86%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	9.54M	14.80%	$2.00M
Artal group	8.59M	13.33%	$2.42M
Logos global management lp	5.40M	8.37%	$1.34M
Adage capital partners gp	5.09M	7.90%	$1.27M
Vr adviser	3.00M	4.65%	$630.00K
Vanguard group	2.67M	4.14%	$664.88K
Wellington management group llp	1.41M	2.19%	$351.94K
Goldman sachs group	804.34K	1.25%	$226.50K
Blackrock funding, inc. /de	728.64K	1.13%	$181.43K
Blackrock	723.18K	1.12%	$203.65K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Logos global management lp	5.40M	0.16%	$1.34M
Bvf inc/il	9.54M	0.08%	$2.00M
Artal group	8.59M	0.06%	$2.42M
Vr adviser	3.00M	0.05%	$630.00K
Intellectus partners	45.97K	0.00%	$11.45K
Adage capital partners gp	5.09M	0.00%	$1.27M
1 north wealth services	12.00K	0.00%	$2.99K
Torno capital	74.70K	0.00%	$21.04K
Jefferies financial group	423.78K	0.00%	$105.52K
Bridgeway capital management	81.80K	0.00%	$23.04K

Top Buyers

Holder	Shares	% Assets	Change
Logos global management lp	5.40M	0.16%	5.40M
Adage capital partners gp	5.09M	0.00%	5.09M
Wellington management group llp	1.41M	0.00%	1.41M
Jefferies financial group	423.78K	0.00%	423.78K
Ubs group	228.87K	-	160.43K

Top Sellers

Holder	Shares	% Assets	Change
Nea management company	-	-	-3.84M
Octagon capital advisors lp	-	-	-3.00M
Siren	-	-	-1.97M
Axa	-	-	-1.59M
Renaissance	41.15K	-	-739.95K

New Positions

Holder	Shares	% Assets	Change	Value
Logos global management lp	5.40M	0.16%	5.40M	$1.34M
Adage capital partners gp	5.09M	0.00%	5.09M	$1.27M
Wellington management group llp	1.41M	0.00%	1.41M	$351.94K
Jefferies financial group	423.78K	0.00%	423.78K	$105.52K
Torno capital	74.70K	0.00%	74.70K	$21.04K

Sold Out

Holder	Change
Fmr	-67.00
Wells fargo & company/mn	-383.00
Old point trust & financial services n a	-500.00
National bank of canada /fi/	-600.00
Qube research	-1.10K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	3	-92.50%	12,558,116	-58.62%	19	0.88%	-	-100.00%	1	-75.00%
Dec 31, 2024	15	-55.88%	5,507,448	-69.04%	8	1.12%	7	-53.33%	1	-90.91%
Sep 30, 2024	33	-19.51%	17,775,290	-30.46%	27	1.75%	14	16.67%	11	-38.89%
Jun 30, 2024	41	-49.38%	25,560,030	-30.64%	39	1.21%	12	-75.51%	18	100.00%
Mar 31, 2024	81	32.79%	36,848,906	4.98%	57	1.92%	49	81.48%	9	-35.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.93M	2.98%	-1.00
Vanguard Total Stock Mkt Idx Inv	1.93M	2.98%	-
Wellington CIF Biotechnology	1.22M	1.89%	1.22M
Vanguard Institutional Extnd Mkt Idx Tr	730.60K	1.13%	-
MEDICAL BioHealth EUR Acc	609.48K	0.95%	-
Fidelity Extended Market Index	322.58K	0.50%	35.13K
BlackRock Extended Equity Market K	107.17K	0.17%	-46.00
Extended Equity Market Fund K	106.04K	0.16%	325.00
iShares Micro-Cap ETF	101.27K	0.16%	-
Fidelity Total Market Index	80.84K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 08, 2024	Invus Public Equities, L.P.	-	Sell	$50.01K
Aug 07, 2024	Invus Public Equities, L.P.	-	Sell	$11.20K
Aug 05, 2024	Invus Public Equities, L.P.	-	Sell	$31.00K
Aug 06, 2024	Invus Public Equities, L.P.	-	Sell	$10.19K
Aug 01, 2024	Invus Public Equities, L.P.	-	Sell	$13.74K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	9
2024 Q2	3	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	2	-

GLYC Ownership FAQ

Who Owns GlycoMimetics?

GlycoMimetics shareholders are primarily institutional investors at 19.48%, followed by 2.66% insiders and 77.86% retail investors. The average institutional ownership in GlycoMimetics's industry, Biotech Stocks , is 63.97%, which GlycoMimetics falls below.

Who owns the most shares of GlycoMimetics?

GlycoMimetics’s largest shareholders are Bvf inc/il (9.54M shares, 14.80%), Artal group (8.59M shares, 13.33%), and Logos global management lp (5.4M shares, 8.37%). Together, they hold 36.50% of GlycoMimetics’s total shares outstanding.

Does Blackrock own GlycoMimetics?

Yes, BlackRock owns 1.12% of GlycoMimetics, totaling 723.18K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 203.65K$. In the last quarter, BlackRock decreased its holdings by -9.383K shares, a -1.28% change.

Who is GlycoMimetics’s biggest shareholder by percentage of total assets invested?

Logos global management lp is GlycoMimetics’s biggest shareholder by percentage of total assets invested, with 0.16% of its assets in 5.4M GlycoMimetics shares, valued at 1.34M$.

Who is the top mutual fund holder of GlycoMimetics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of GlycoMimetics shares, with 2.98% of its total shares outstanding invested in 1.93M GlycoMimetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools